Industry News

SQI Diagnostics Inc., today announced the sale of a sqid lite™ system under the terms of an agreement with a top tier global pharmaceutical customer. In partnership with this customer, SQI has developed several unique multiplexed assays utilizing its proprietary technology. SQI's customer is currently running these tests in their laboratory to generate data from drug study patient samples on SQI's automated system."/>
SQI Sells Sqidlite System to Global Pharmaceutical Customer
SQI Diagnostics Inc., today announced the sale of a sqid lite™ system under the terms of an agreement with a top tier global pharmaceutical customer. In partnership with this customer, SQI has developed several unique multiplexed assays utilizing its proprietary technology. SQI's customer is currently running these tests in their laboratory to generate data from drug study patient samples on SQI's automated system."/>
SQI Sells Sqidlite System to Global Pharmaceutical Customer
Mitsubishi Tanabe Pharma Corporation, today announced that the U.S. Food and Drug Administration has accepted the company's New Drug Application for edaravone an intravenous treatment for amyotrophic lateral sclerosis, a rapidly progressive neurological disease. A decision on the application is anticipated on June 16, 2017 based on the Prescription Drug User Fee Act."/>
FDA Accepts Mitsubishi Tanabe Pharma's NDA Filing for Edaravone to Treat ALS
Nutra Pharma Corporation, a biotechnology company marketing Nyloxin ® and Pet Pain-Away™ in the over-the-counter pain management market, announced today the appointment of Maj. Kenneth Dowd, US Army as Strategic Advisor for the Company's newly created' Military& Veterans' business segment. General Dowd will support Nutra Pharma's efforts in presenting the Company's non-opiate, non-narcotic over-the-counter pain solution, Nyloxin ® to the US..."/>
Nutra Pharma Announces Addition of Maj. Gen. Kenneth Dowd to Its Advisory Board
RegeneRx Biopharmaceuticals, Inc., a clinical-stage drug development company focused on tissue protection, repair and regeneration, today announced that J.J. Finkelstein, President and Chief Executive Officer, will present a corporate overview at the Rodman& Renshaw 18th Annual Global Investment Conference taking place on September 11-13, 2016 at the Lotte New York Palace Hotel in New York City. Finkelstein will present on Monday..."/>
RegeneRx to Present at Rodman & Renshaw 18th Annual Global Investment Conference
Boston Scientific Corporation will participate in the Morgan Stanley Global Healthcare Conference on September 13, in New York City. Mike Mahoney, chief executive officer, and Dan Brennan, executive vice president and chief financial officer, will participate in a 30- minute question-and-answer-session with the host analyst beginning at approximately 8:00 a.m. EDT. A live webcast of the question-and-answer-session will be..."/>
Boston Scientific To Participate In Morgan Stanley Global Healthcare Conference
St. Jude Medical Device Security Feature, Not a Flaw. Jude Medical, Inc., a global medical device company, today issued the following statement:."/>
St. Jude Medical Continues to Refute Allegations made by Muddy Waters Capital and MedSec
Medidata Solutions and other healthcare and technology industry leaders. SHYFT will use the investment to continue its rapid growth and expansion and further advance..."/>
SHYFT Analytics Raises $12.5 Million in New Funding From Global Healthcare and Technology Leaders, Led by McKesson Ventures and Medidata Solutions
WellCare Health Plans, Inc. announced today that it gave $5,000 in micro-grants to five community-based organizations in Nevada. These micro-grants went to nonprofit and 501 (c) organizations that address needs related to homelessness, mental illness, substance abuse and grieving children. The micro-grants were given in denominations of $1,000.."/>
WellCare Gives $5,000 in Micro-Grants to Community-Based Organizations in Nevada
DelMar Pharmaceuticals, Inc., a biopharmaceutical company focused on the development and commercialization of new cancer therapies, today announced that it will be presenting at the 18th Annual Rodman& Renshaw Global Investment Conference being held September 11-13, 2016, at the Lotte New York Palace Hotel in New York City. Jeffrey Bacha, DelMar's president and CEO, will present at the Conference on..."/>
DelMar Pharmaceuticals to Present at the 18th Annual Rodman & Renshaw Global Investment Conference on September 13, 2016
Spotlight Innovation Inc. announced today that Prof. Hengli Tang has co-authored a study 1, published in Nature Medicine on August 29, 2016, reporting two classes of compounds: one that protects Zika virus-infected neural cells from programmed cell death and another that directly inhibits Zika virus replication. According to the study, when used in combination, compounds from the two classes enhanced the neuroprotective effect."/>
Spotlight Innovation Research Collaborator Prof. Hengli Tang Publishes Landmark Study in Nature Medicine
Skyline Medical to hold conference call on September 8, 2016 at 12:00 p.m. Eastern time MINNEAPOLIS, Aug. 30, 2016-- Skyline Medical Inc., developer of the innovative STREAMWAY ® waste fluid disposal system for medical applications, announces the signing of a letter of intent to form a joint venture with Electronic On-Ramp, Inc., a..."/>
Skyline Medical Signs Letter of Intent to Form Joint Venture with Electronic On-Ramp
bluebird bio, Inc., a clinical-stage company committed to developing potentially transformative gene therapies for severe genetic diseases and T cell-based immunotherapies for cancer, today announced that members of the management team will present at the following upcoming investor conferences:. Citi 11 th Annual Biotech Conference on September 7, 2016. Panel discussion at 1:00 p.m. ET at the Mandarin Oriental Hotel in Boston. Wells Fargo Securities..."/>
Bluebird bio to Present at Four Upcoming Conferences
Bovie Medical, a maker of medical devices and supplies and the developer of J-Plasma ®, a patented new surgical product, announced that the Bovie ® J-Plasma ® product extension, branded the Precise 360™, has been named an“ Innovation of the Year” by The Society of Laparoendoscopic Surgeons. This J-Plasma ® hand piece has an angled and rotating tip that enables surgeons access..."/>
Bovie J-Plasma® Precise 360™ Handpiece Named ‘Innovation of the Year’ by the Society of Laparoendoscopic Surgeons (SLS)
Keryx Biopharmaceuticals Inc., Inovio Pharmaceuticals Inc., Seattle Genetics Inc., and Arrowhead Pharmaceuticals Inc.."/>
Technical Roundup on Biotech Stocks -- Keryx Biopharma, Inovio Pharma, Seattle Genetics, and Arrowhead Pharma
Oragenics, a leader in the development of novel antibiotics against infectious disease and developing effective treatments for oral mucositis today announced that it has received feedback from the U.S. Food and Drug Administration in response to the Company’ s request for a Type C meeting, concerning Phase 2 study protocols for the Company’ s OM therapeutic candidate, AG013. As part of the clinical protocol for the study, Oragenics expects to file the..."/>
Oragenics Receives Supportive FDA Feedback for Initiating a Phase 2 Study Protocol for Oral Mucositis Treatment
Varian Medical Systems announced the installation of a Clinac ® iX medical linear accelerator at Instituto Oncologico del Oriente Boliviano in Santa Cruz, Bolivia. First patient treatments were started earlier in August. In addition to the installation of the Clinac iX, Varian in conjunction with its distributor in Bolivia, HP Medical, held a two..."/>
Varian Expands Access to Advanced Cancer Care in Bolivia
DaVita HealthCare Partners Inc., and a leading independent provider of integrated health and kidney care services in the United States, welcomes Bryan Becker, MD, MMM, FACP, CPE as vice president of integrated care and member of the Office of the Chief Medical Officer, DaVita's physician leadership team. Becker will lead the clinical programs for VillageHealth at DaVita HealthCare Partners. Becker's career is..."/>
DaVita Kidney Care Welcomes Dr. Bryan Becker to Physician Leadership Team
Mazor Robotics Ltd., a developer of innovative guidance systems and complementary products, installed a Renaissance ® Guidance System at Grand Strand Medical Center in Myrtle Beach, SC on July 6, 2016 and has since completed an initial case series. Grand Strand is the second in the state of South Carolina and the ninth HCA-affiliated facility to purchase a Renaissance system. See how Renaissance works. "One of our main goals is to help improve outcomes for..."/>
South Carolina HCA Affiliate, Grand Strand Medical Center, is First in the Region with a Mazor Robotics Renaissance(R) Spine Program
Insys Therapeutics, Inc.. After the close of the market on April 24, 2015 the Southern Investigating Report Foundation published an article reporting on patients who either died or suffered adverse events while being treated with Subsys, and..."/>
Purcell Julie & Lefkowitz LLP Is Investigating Insys Therapeutics, Inc. for Potential Breaches Of Fiduciary Duty By Its Board of Directors

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Most Popular Sectors in the News
Sectors Articles in the last 7 days
Consumer Discretionary576 Articles
Information Technology528 Articles
Financials442 Articles
Industrials315 Articles
Health Care314 Articles

Sponsored Financial Commentaries

Request Profile Update

Only a company representative may request an update for the company profile. Documentation will be required.

To contact , please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.